While I agree with you that scientists are not exactly going to be concerned with stockholder issues, BMSN is a publicly traded company. Koos and what ever other employee(s) he has to help him surely are aware that his stockholders are going to have concerns. That being the case, who exactly is fielding stockholder concerns other than Koos, that is if you know? And no, I yet to have any contact with the company but I might soon to see what and if any response I get. And yes, for those interested, I have an educated bet on this company because I understand the potential of regenerative medicine. Pro American athletes aren't going to Europe to have it done for nothing.